利伐沙班在国内的价格

The tablet is generally used for the treatment and recovery of adult patients undergoing elective hip or knee replacement surgery to prevent abnormal veins and the formation of blood clots. Rivaroxaban is an oral, bioavailable factor Xa inhibitor that selectively blocks the active site of factor Xa and does not require cofactors (such as antithrombin III) for activity. Factor X is activated into factor Xa (FXa) through endogenous and exogenous pathways, which plays an important role in the coagulation cascade.

Rivaroxaban is a highly selective, oral drug that directly inhibits factor Xa. Compared with warfarin, its effect is safe, effective and lasts for a long time, and does not require monitoring of coagulation. By inhibiting factor Rivaroxaban does not inhibit thrombin (activated factor II) and has no proven effect on platelets. A dose-dependent inhibition of factor Xa activity by rivaroxaban has been observed in humans. The effect of rivaroxaban on prothrombin time (PT) has a dose-effect relationship. If NeopLastin is used for content measurement, it is closely related to the plasma concentration (correlation coefficient is 0.98). Different results may occur with other reagents. Reading the PT should be completed within seconds because the International Normalized Ratio (INR) is calibrated and validated only for coumarins and not for other anticoagulants. A newly published study shows that the new anticoagulant drug rivaroxaban from Bayer Healthcare of Germany can effectively reduce the formation of venous thrombosis in patients after major orthopedic surgery, and its efficacy is better than the current standard treatment of enoxaparin.

An international scientific research team published a paper in the journal "The Lancet" stating that through analysis of data from a multi-center, randomized, double-blind clinical trial called "BECORD4", among a total of more than 3,000 patients, researchers confirmed that compared with standard therapy using enoxaparin, patients treated with rivaroxaban reduced the risk of venous thromboembolism after orthopedic surgery by about one-third.

Through the above content, we have seen the therapeutic effect of rivaroxaban. So what is the domestic selling price of rivaroxaban? According to Medical Travel, the price of 10 mg Since the exchange rate is floating and the price is not fixed, if patients need to purchase medicines, please consult Medical Travel for specific prices.